Jim Kelly's cancer has reached the base of his skull, but doctors view that tumor as operable down the road.
Instead, the chemotherapy and radiation regimen Kelly's scheduled to begin Monday will target "cancer cells in his maxillary sinus and adjacent tissues," Lenox Hill Hospital announced today in a statement.
A column by Sports Illustrated writer Peter King on Monday revealed Kelly's cancer has spread up the infraorbital nerve, which connects the upper lip to the lower eyelid.
Lenox Hill cited Dr. Peter D. Costantino, executive director of the Manhattan-based hospital's New York Head & Neck Institute.
The statement explained Kelly will have a chemotherapy treatment next week, then again in three weeks and once more in six weeks. At the same time, he will receive daily radiation treatments at the North Shore-LIJ Cancer Institute's Center for Advanced Medicine.
"At the conclusion of chemotherapy and radiation," Constantino said in the Lenox Hill statement, "we will wait two to three months to determine the status of his cancer before deciding if surgery will be necessary."
The statement also noted Kelly hasn't had chemo or radiation therapies before and suggested that portends a positive impact on his cancer.
"As I have stated previously, Jim Kelly’s condition remains very treatable and potentially curable," Constantino said. "Even if chemotherapy and radiation are not successful in eradicating the cancer, his skull-base tumor remains operable."